Li Ding
Impact in
- Immunology top 0.5%
- Immunodeficiency and Autoimmune Disorders
- interferon and immune responses
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Immunology 32
- Immunodeficiency and Autoimmune Disorders 21
-
- Infections and bacterial resistance 9
- Co-authors
- Steven M. Holland (34 shared papers)Yu Chen (27 shared papers)Wei Feng (9 shared papers)Caihong Dong (8 shared papers)Meiqi Chang (14 shared papers)Wen Sheng Shi (1 shared paper)Hui Huang (6 shared papers)Jianlin Shi (3 shared papers)
- Journals
- Advanced Functional Materials (6 papers)Annals of Translational Medicine (5 papers)Journal of Allergy and Clinical Immunology (5 papers)Chinese Chemical Letters (5 papers)Advanced Materials (4 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Li Ding
165 papers receiving 9.4k citations
Li Ding's Hit Papers
Peers
Comparison fields: 5 of 156
- Immunology 2.5k
- Infectious Diseases 1.8k
- Epidemiology 1.5k
- Microbiology 32
- Biomedical Engineering 1k
Countries citing papers authored by Li Ding
This map shows the geographic impact of Li Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ding more than expected).
Fields of papers citing papers by Li Ding
This network shows the impact of papers produced by Li Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ding. The network helps show where Li Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2107 |
| 2 | Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome Hit paper breakdown → | 2011 | 540 |
| 3 | 2012 | 445 | |
| 4 | 2008 | 379 | |
| 5 | 2009 | 278 | |
| 6 | 2006 | 236 | |
| 7 | 2013 | 208 | |
| 8 | 2018 | 204 | |
| 9 | 2013 | 203 | |
| 10 | 2017 | 184 | |
| 11 | 2005 | 177 | |
| 12 | 2017 | 164 | |
| 13 | 2012 | 152 | |
| 14 | 2022 | 145 | |
| 15 | 2017 | 142 | |
| 16 | 2010 | 130 | |
| 17 | 2020 | 126 | |
| 18 | 2021 | 122 | |
| 19 | 2006 | 107 | |
| 20 | 2016 | 95 |
About Li Ding
Li Ding is a scholar working on Immunology, Endocrinology, Biomedical Engineering, Epidemiology and Complementary and alternative medicine, having authored 172 papers that have together received 9.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (27 papers), Immunodeficiency and Autoimmune Disorders (21 papers), Infections and bacterial resistance (9 papers), Mycobacterium research and diagnosis (6 papers), Traditional Chinese Medicine Analysis (6 papers), Clinical practice guidelines implementation (5 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Phytochemistry and Biological Activities (5 papers). The work is most often cited by research in Immunology (2.5k citations), Infectious Diseases (1.8k citations), Epidemiology (1.5k citations), Microbiology (32 citations) and Biomedical Engineering (1k citations). Li Ding has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Steven M. Holland, Yu Chen, Wei Feng, Caihong Dong, Meiqi Chang, Wen Sheng Shi, Hui Huang, Jianlin Shi, Xianbing Zhu and Sarah Browne. Their work appears in journals such as Advanced Functional Materials, Annals of Translational Medicine, Journal of Allergy and Clinical Immunology, Chinese Chemical Letters and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.